阅读下面的文字,完成文后五题。有些人根本不了解文字和思想情感的密切关系,以为更改一两个字不过是要文字顺畅些或是漂亮些。其实更动了文字,就同时更动了思想情感,内容和形式是相随而变的。姑举一个人人皆知的实例。韩愈在月夜里听见贾岛吟诗,有“鸟宿池边树,僧推月下门”两句,劝他把“推”字改成“敲”字。这段文字因缘古今传为关谈,今人要把咬文嚼字的意思说得好听一点,都说“推敲”。古今人也都赞赏“敲”字比“推”字下得好。其实这不仅是文字上的分别,同时也是意境上的分别。“推”固然显得鲁莽一点,但是它表示孤僧步月归寺,门原来是他自己掩的,如今他“推”。他须自掩自推,足见寺里只有他孤零零的一个和尚。在这冷寂的场合,他有兴致出来步月,兴尽而返,独往独来,自在无碍,他也自有一副胸襟气度。“敲”就显得他拘礼些,也就显得寺里有人应门。他仿佛是乘月夜访友,他自己不甘寂寞,那寺里假如不是热闹场合,至少也有一些温暖的人情。比较起来,“敲”的空气没有“推”的那么冷寂。就上句“鸟宿池边树”看来,“推”似乎比“敲”要调和些。“推”可以无声,“敲”就不免剥啄有声,惊起了宿鸟,打破了岑寂,也似乎平添了搅扰。所以我很怀疑韩愈的修改是否真如古今所称赏的那么妥当。究竟哪一种意境是贾岛当时在心里玩索而要表现的,只有他自己知道。如果他想到“推”而下“敲”字,或是想到“敲”而下“推”字,我认为那是不可能的事。所以问题不在“推”字和“敲”字哪一个比较恰当,而在哪一种境界是他当时所要说的而且与全诗调和的。在文字上推敲,骨子里实在是在思想情感上“推敲”。节选自朱光潜《咬文嚼字》 学习本文,我们可以在学习和运用语言方面获得很多启示。下面说法不恰当的一项是()。
A. 语言文字的品味,要“咬”要“嚼”,要细细地咀嚼,要有一字不肯放松的精神。
B. 咬文嚼字,也要有思路,或由表及里,或由此及彼,这样品味才能到位。
C. 品味语言也要独立思考,不迷信,不盲从,也要努力创新。
D. 品味语言,要有卓越的见识,深刻的思想,只有加强思想修养,才能学好。
根据下列文字回答下列问题。据统计,2006年5月份全国基本型乘用车产销21.19万辆和22.13万辆,比2005年同期分别增长1.86%和26.03%;运动型多用途乘用车产销1.43万辆和1.52万辆,降幅不大;交叉型乘用车5月产销6.60万辆和6.85万辆,分别比上月下降14.23%和2.83%;多功能乘用车产销降幅最大,5月产销1.23万辆和1.24万辆。2006年1至5月,基本型乘用车累计产销99.10万辆和96.93万辆,产量同比下降2.73%,销量同比增长1.07%;多功能乘用车累计产销6.11万辆和5.71万辆,同比增长31.26%和 31.54%;运动型多用途乘用车累计产销6.46万辆和6.54万辆,同比下降16.00%和10.25%;交叉型乘用车累计产销36.77万辆和37.41万辆,同比增长6.02%和10.29%。 2006年5月份全国多功能乘用车的产量占1至5月份总产量的()。
A. 20.13%
B. 22.14%
C. 17.95%
D. 21.38%
根据下列文字回答下列问题。据统计,2006年5月份全国基本型乘用车产销21.19万辆和22.13万辆,比2005年同期分别增长1.86%和26.03%;运动型多用途乘用车产销1.43万辆和1.52万辆,降幅不大;交叉型乘用车5月产销6.60万辆和6.85万辆,分别比上月下降14.23%和2.83%;多功能乘用车产销降幅最大,5月产销1.23万辆和1.24万辆。2006年1至5月,基本型乘用车累计产销99.10万辆和96.93万辆,产量同比下降2.73%,销量同比增长1.07%;多功能乘用车累计产销6.11万辆和5.71万辆,同比增长31.26%和 31.54%;运动型多用途乘用车累计产销6.46万辆和6.54万辆,同比下降16.00%和10.25%;交叉型乘用车累计产销36.77万辆和37.41万辆,同比增长6.02%和10.29%。 2006年5月份全国乘用车销量最大的车型是()。
A. 基本型乘用车
B. 交叉型乘用车
C. 多功能乘用车
D. 运动型多用途乘用车
Small, pink and very ugly. Hardly the qualities of a star, but they describe the deformed mouse that was the media darling at a recent science exhibition in Beijing. With a complex tissue structure in the shape of a human ear grafted on to its back, the rosy rodent was a stunning symbol of the serious strides China is making in the field of biotechnology.China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It’s establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.For the moment, the cooperation exists mostly with Europe and the U. S. But Asia’s other biotech leaders, Japan, Singapore and Korea, also are recognizing China’s potential as an attractive low-cost base to conduct research. These partnerships--and China’s advancement in the field of biotechnology--could help benefit the rest of Asia: China’s rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven’t met one scientist who believes they are being fully adhered to," says a European science analyst.If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China. As implied in the context, the shortcuts that might be taken include ()
A. publicizing recent achievements in the official press
B. the protection of innovators with their products
C. the violation of intellectual-property rights
D. making lab tests as strict as possible